Theravance Reports Third Quarter 2010 Financial Results – MarketWatch (press release)

Theravance Reports Third Quarter 2010 Financial Results
MarketWatch (press release)
"The RELOVAIR(TM) Phase 3 programs in COPD and asthma are progressing well and have now enrolled over 8000 patients. Last month, preclinical and Phase 2a

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.